Envision and AMSURG Announce Pricing of $550 Million Senior Notes Offering by New Amethyst Corp. (To Be Renamed Envision Healthcare Corporation)

GREENWOOD VILLAGE, Colo. & NASHVILLE, Tenn.--(BUSINESS WIRE)--In connection with the proposed merger of Envision Healthcare Holdings, Inc. (NYSE: EVHC) (“Envision”) and AMSURG Corp. (NASDAQ: AMSG) (“AMSURG”) (the “Merger”), Envision and AMSURG today announced that New Amethyst Corp., to be renamed Envision Healthcare Corporation (the “Company”), a wholly owned subsidiary of AMSURG that will survive the Merger, has priced the private offering of $550 million aggregate principal amount of its 6.25% Senior Notes due 2024 (the “Notes”). The offering is expected to close on December 1, 2016, subject to customary closing conditions. If the closing of the Notes occurs prior to the date of the completion of the Merger, the proceeds of the offering of the Notes will be deposited into an escrow account pending the consummation of the Merger.